Ignite Creation Date:
2025-12-24 @ 9:48 PM
Ignite Modification Date:
2026-01-03 @ 10:58 PM
Study NCT ID:
NCT05983432
Status:
RECRUITING
Last Update Posted:
2025-12-15
First Post:
2023-07-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
Sponsor:
SystImmune Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Non Small Cell Lung Cancer | View |
| None | Lung Cancer | View |
| None | Breast Cancer | View |
| None | Esophageal Cancer | View |
| None | Small Cell Lung Cancer | View |
| None | Nasopharyngeal Cancer | View |
| None | Head and Neck Squamous Cell Carcinoma | View |
| None | Prostate Adenocarcinoma | View |
| None | Ovarian Cancer | View |
| None | Endometrial Cancer | View |
| None | Cervical Cancer | View |
| None | Triple Negative Breast Cancer | View |
Keywords: